2024-03-29T10:36:02Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_C789AFF3E53C
2024-03-23T02:58:04Z
serval:BIB_C789AFF3E53C
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.
10.1200/JCO.2015.63.6563
26786929
000374333400019
Happold
C.
author
Gorlia
T.
author
Chinot
O.
author
Gilbert
M.R.
author
Nabors
L.B.
author
Wick
W.
author
Pugh
S.L.
author
Hegi
M.
author
Cloughesy
T.
author
Roth
P.
author
Reardon
D.A.
author
Perry
J.R.
author
Mehta
M.P.
author
Stupp
R.
author
Weller
M.
author
article
2016
Journal of Clinical Oncology
1527-7755
0732-183X
journal
34
7
731-739
Adolescent
Adult
Aged
Anticonvulsants/therapeutic use
Antineoplastic Agents, Alkylating/therapeutic use
Brain Neoplasms/complications
Brain Neoplasms/drug therapy
Chemoradiotherapy
Clinical Trials as Topic
Dacarbazine/analogs & derivatives
Dacarbazine/therapeutic use
Epilepsy/drug therapy
Epilepsy/etiology
Female
Glioblastoma/complications
Glioblastoma/drug therapy
Humans
Male
Middle Aged
Piracetam/analogs & derivatives
Piracetam/therapeutic use
Prognosis
Survival Analysis
Valproic Acid/therapeutic use
eng
60_published
peer-reviewed